FDA Grants De Novo Marketing Authorization for the Distalmotion Dexter® Surgical Robot
October 28, 2024 05:00 ET
|
Distalmotion
Lausanne, Switzerland, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Distalmotion has been granted De Novo approval by the U.S. Food and Drug Administration (FDA) to market the Dexter Surgical Robot for adult...
Industry Leader Greg Roche Joins Distalmotion as CEO
December 07, 2023 11:00 ET
|
Distalmotion
Lausanne, Switzerland, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Distalmotion, a pioneer in novel, on-demand robotics, has hired medical device industry leader, Greg Roche, as CEO. Subject to shareholder...
Industry Leader Greg Roche Joins Distalmotion as CEO
December 07, 2023 03:00 ET
|
Distalmotion
Lausanne, Switzerland, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Distalmotion, a pioneer in novel, on-demand robotics, has hired medical device industry leader, Greg Roche, as CEO. Subject to shareholder...